Sodium–Glucose Cotransporter Inhibitors Reduce Mortality and Morbidity in Patients With Heart Failure-Reference-Cited by-同舟云学术

Sodium–Glucose Cotransporter Inhibitors Reduce Mortality and Morbidity in Patients With Heart Failure

Published:2021-11-24 Issue: Volume:Publish Ahead of Print Page:
ISSN:1075-2765
Container-title:American Journal of Therapeutics
language:en
Short-container-title:

Author:

Camilli Massimiliano,Lombardi Marco,Chiabrando Juan G.,Zito Andrea,Del Buono Marco G.,Vergallo Rocco,Aspromonte Nadia,Lombardo Antonella,Montone Rocco A.,Niccoli Giampaolo,Biondi-Zoccai Giuseppe,Crea Filippo,Minotti Giorgio

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pharmacology (medical),Pharmacology,General Medicine

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sodium–Glucose Transporter 2 Inhibitors in Heart Failure: An Overview of Systematic Reviews;Journal of Cardiovascular Development and Disease;2024-06-28

2. Sodium–glucose cotransporter 2 inhibitors and the cancer patient: from diabetes to cardioprotection and beyond;Basic Research in Cardiology;2024-06-27

3. Cost-Effectiveness of Sodium–Glucose Cotransporter-2 Inhibitors for Patients With Heart Failure in China: A New Pillar in Our Pockets, but at What Price?;Journal of Cardiovascular Pharmacology;2024-01

4. Early improvement of strain imaging parameters predicts long-term response to sacubitril/valsartan in patients with heart failure with reduced ejection fraction: An observational prospective study;International Journal of Cardiology;2023-09

5. The effect of SGLT2i on in-hospital acute heart failure risk in acute myocardial infarction patients—a retrospective study;Frontiers in Cardiovascular Medicine;2023-05-16